medmix publishes a midyear report as well as an annual report.
Kettenbach/Xinial legally prevented from manufacture or offer for sale in Germany
Kettenbach/Xinial legally compelled to recall and destroy infringing system
medmix Switzerland Ltd. continues to enforce its rights
Ad hoc announcement pursuant to Art. 53 LR
Full-year 2023 revenue growth and profitability within communicated range
Improving trends expected throughout full-year 2024
medmix Switzerland Ltd. continues to enforce its rights
medmix Drug Delivery (Haselmeier) launches its passive needle safety device SicuroJect™ at Pharmapack Europe in Paris, further expanding its product portfolio.
medmix wins 2024 BIG Innovation Award for MIXPAC™ greenLine™ 400 mL 1:1 two-component cartridge set made from up to 100% recycled plastic.
Ad hoc announcement pursuant to Art. 53 LR
medmix (SIX: MEDX) today announced its intention to enter into a strategic investment, representing a 25% stake, in AARDEX to reinforce medmix' drug delivery business under the HaselmeierTM brand. AARDEX is a global Software as a Service (SaaS) provider of digital solutions for measuring and managing medication adherence in clinical trials.
medmix is excited to introduce ZerofloX, an innovative new flock-free micro applicator that provides a superior user experience for best esthetics.
medmix announces the sale of medmix Poland sp. z.o.o and the removal of this entity from sanctions list.
Ad hoc announcement pursuant to Art. 53 LR
Solid underlying business momentum in H1 2023 restrained by transitory factors
Strong performance expected in H2 2023 with mid-term outlook confirmed
New FY 2023 profit margin guidance reflects timing factors within H2 2023
medmix, a global leader in high-precision delivery devices, announces the successful completion of its acquisition of China-based Guangdong Qiaoyi Plastic Co. Ltd., following the announcement made in January 2023. This acquisition allows medmix to rapidly expand its global Beauty footprint in Asia.
The global market of hot melt adhesives is projected to grow substantially through 2029*. One of the main drivers will be increased demand for advanced consumer electronic products. With the new MIXPAC 30 mL purHT 1K cartridge kit from medmix, end-users will be able to significantly boost their bonding performance and meet this trend.